152 related articles for article (PubMed ID: 22521610)
1. Gender-specific reduction of hepatic Mrp2 expression by high-fat diet protects female mice from ANIT toxicity.
Kong B; Csanaky IL; Aleksunes LM; Patni M; Chen Q; Ma X; Jaeschke H; Weir S; Broward M; Klaassen CD; Guo GL
Toxicol Appl Pharmacol; 2012 Jun; 261(2):189-95. PubMed ID: 22521610
[TBL] [Abstract][Full Text] [Related]
2. ANIT-induced intrahepatic cholestasis alters hepatobiliary transporter expression via Nrf2-dependent and independent signaling.
Tanaka Y; Aleksunes LM; Cui YJ; Klaassen CD
Toxicol Sci; 2009 Apr; 108(2):247-57. PubMed ID: 19181614
[TBL] [Abstract][Full Text] [Related]
3. Role of MRP2 and GSH in intrahepatic cycling of toxins.
Dietrich CG; Ottenhoff R; de Waart DR; Oude Elferink RP
Toxicology; 2001 Oct; 167(1):73-81. PubMed ID: 11557131
[TBL] [Abstract][Full Text] [Related]
4. Compensatory induction of liver efflux transporters in response to ANIT-induced liver injury is impaired in FXR-null mice.
Cui YJ; Aleksunes LM; Tanaka Y; Goedken MJ; Klaassen CD
Toxicol Sci; 2009 Jul; 110(1):47-60. PubMed ID: 19407337
[TBL] [Abstract][Full Text] [Related]
5. Geniposidic acid protected against ANIT-induced hepatotoxity and acute intrahepatic cholestasis, due to Fxr-mediated regulation of Bsep and Mrp2.
Chen H; Huang X; Min J; Li W; Zhang R; Zhao W; Liu C; Yi L; Mi S; Wang N; Wang Q; Zhu C
J Ethnopharmacol; 2016 Feb; 179():197-207. PubMed ID: 26723467
[TBL] [Abstract][Full Text] [Related]
6. Investigations of the total flavonoids extracted from flowers of Abelmoschus manihot (L.) Medic against α-naphthylisothiocyanate-induced cholestatic liver injury in rats.
Yan JY; Ai G; Zhang XJ; Xu HJ; Huang ZM
J Ethnopharmacol; 2015 Aug; 172():202-13. PubMed ID: 26133062
[TBL] [Abstract][Full Text] [Related]
7. Alisol B 23-acetate protects against ANIT-induced hepatotoxity and cholestasis, due to FXR-mediated regulation of transporters and enzymes involved in bile acid homeostasis.
Meng Q; Chen XL; Wang CY; Liu Q; Sun HJ; Sun PY; Huo XK; Liu ZH; Yao JH; Liu KX
Toxicol Appl Pharmacol; 2015 Mar; 283(3):178-86. PubMed ID: 25655198
[TBL] [Abstract][Full Text] [Related]
8. Naphthylisothiocyanate disposition in bile and its relationship to liver glutathione and toxicity.
Jean PA; Roth RA
Biochem Pharmacol; 1995 Oct; 50(9):1469-74. PubMed ID: 7503798
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol effectively attenuates α-naphthyl-isothiocyanate-induced acute cholestasis and liver injury through choleretic and anti-inflammatory mechanisms.
Wang T; Zhou ZX; Sun LX; Li X; Xu ZM; Chen M; Zhao GL; Jiang ZZ; Zhang LY
Acta Pharmacol Sin; 2014 Dec; 35(12):1527-36. PubMed ID: 25418378
[TBL] [Abstract][Full Text] [Related]
10. The role of invariant natural killer T cells in experimental xenobiotic-induced cholestatic hepatotoxicity.
Nong C; Zou M; Xue R; Bai L; Liu L; Jiang Z; Sun L; Huang X; Zhang L; Wang X
Biomed Pharmacother; 2020 Feb; 122():109579. PubMed ID: 31794947
[TBL] [Abstract][Full Text] [Related]
11. Early growth response factor-1 limits biliary fibrosis in a model of xenobiotic-induced cholestasis in mice.
Sullivan BP; Cui W; Copple BL; Luyendyk JP
Toxicol Sci; 2012 Mar; 126(1):267-74. PubMed ID: 22094456
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of n-Butanol extract and iridoid glycosides of Veronica ciliata Fisch. Against ANIT-induced cholestatic liver injury in mice.
Hua W; Zhang S; Lu Q; Sun Y; Tan S; Chen F; Tang L
J Ethnopharmacol; 2021 Feb; 266():113432. PubMed ID: 33011367
[TBL] [Abstract][Full Text] [Related]
13. Protection against alpha-naphthylisothiocyanate-induced liver injury by decreased hepatic non-protein sulfhydryl content.
Dahm LJ; Roth RA
Biochem Pharmacol; 1991 Aug; 42(6):1181-8. PubMed ID: 1679629
[TBL] [Abstract][Full Text] [Related]
14. Roles of P-glycoprotein, Bcrp, and Mrp2 in biliary excretion of spiramycin in mice.
Tian X; Li J; Zamek-Gliszczynski MJ; Bridges AS; Zhang P; Patel NJ; Raub TJ; Pollack GM; Brouwer KL
Antimicrob Agents Chemother; 2007 Sep; 51(9):3230-4. PubMed ID: 17576841
[TBL] [Abstract][Full Text] [Related]
15. Temporal relationship of changes in hepatobiliary function and morphology in rats following alpha-naphthylisothiocyanate (ANIT) administration.
Kossor DC; Meunier PC; Handler JA; Sozio RS; Goldstein RS
Toxicol Appl Pharmacol; 1993 Mar; 119(1):108-14. PubMed ID: 8470113
[TBL] [Abstract][Full Text] [Related]
16. Target profiling analyses of bile acids in the evaluation of hepatoprotective effect of gentiopicroside on ANIT-induced cholestatic liver injury in mice.
Tang X; Yang Q; Yang F; Gong J; Han H; Yang L; Wang Z
J Ethnopharmacol; 2016 Dec; 194():63-71. PubMed ID: 27582267
[TBL] [Abstract][Full Text] [Related]
17. Relationship between alpha-naphthylisothiocyanate-induced liver injury and elevations in hepatic non-protein sulfhydryl content.
Dahm LJ; Bailie MB; Roth RA
Biochem Pharmacol; 1991 Aug; 42(6):1189-94. PubMed ID: 1679630
[TBL] [Abstract][Full Text] [Related]
18. Limited role for CXC chemokines in the pathogenesis of alpha-naphthylisothiocyanate-induced liver injury.
Xu J; Lee G; Wang H; Vierling JM; Maher JJ
Am J Physiol Gastrointest Liver Physiol; 2004 Sep; 287(3):G734-41. PubMed ID: 15130876
[TBL] [Abstract][Full Text] [Related]
19. ANIT-induced disruption of biliary function in rat hepatocyte couplets.
Orsler DJ; Ahmed-Choudhury J; Chipman JK; Hammond T; Coleman R
Toxicol Sci; 1999 Feb; 47(2):203-10. PubMed ID: 10220858
[TBL] [Abstract][Full Text] [Related]
20. Alpha-naphthylisothiocyanate modulates hepatobiliary transporters in sandwich-cultured rat hepatocytes.
Guo C; He L; Yao D; A J; Cao B; Ren J; Wang G; Pan G
Toxicol Lett; 2014 Jan; 224(1):93-100. PubMed ID: 24120425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
